Novelion Therapeutics Inc (NVLNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 0 | 0 | 0 | 0 | 42,106 |
| Cost of Goods | N/A | N/A | N/A | N/A | 20,198 |
| Gross Profit | N/A | N/A | N/A | N/A | 21,908 |
| Operating Expenses | 28,490 | 54,675 | 41,394 | 26,412 | 76,444 |
| Operating Income | -28,490 | -54,675 | -41,394 | -26,412 | -54,338 |
| Interest Expense | 0 | 0 | 0 | 0 | 1,848 |
| Other Income | 3,251 | 8,511 | 11,216 | 19,268 | 14,649 |
| Pre-tax Income | -25,239 | -46,164 | -30,178 | -7,144 | -41,537 |
| Income Tax | 599 | -3,900 | 1,201 | 2,126 | -5,317 |
| Net Income Continuous | -25,838 | -42,264 | -31,379 | -9,270 | -36,220 |
| Net Income Discontinuous | 967 | 87,962 | 963 | -8,269 | 135,654 |
| Net Income | $-24,871 | $45,698 | $-30,416 | $-17,539 | $99,434 |
| EPS Basic Total Ops | -2.45 | 4.55 | -3.05 | -1.65 | 8.85 |
| EPS Basic Continuous Ops | -2.55 | -4.20 | -3.15 | -0.90 | -3.20 |
| EPS Basic Discontinuous Ops | 0.10 | 8.75 | 0.10 | -0.75 | 12.05 |
| EPS Diluted Total Ops | -2.45 | 4.55 | -3.05 | -1.65 | 8.85 |
| EPS Diluted Continuous Ops | -2.55 | -4.20 | -3.15 | -0.90 | -3.20 |
| EPS Diluted Discontinuous Ops | 0.10 | 8.75 | 0.10 | -0.75 | 12.05 |
| EPS Diluted Before Non-Recurring Items | -2.40 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-27,526 | $-53,421 | $-39,961 | $-25,210 | $-52,935 |